Beth Seidenberg

About

Beth Seidenberg, M.D. is the Founding Managing Director of Westlake Village BioPartners. She was a General Partner at Kleiner Perkins. Beth has incubated and invested in more than 40 biotech companies since 2005 across many therapeutic areas and modalities. She currently sits on the following public company boards: Acelyrin, Kyverna, Progyny, Sagimet and Vera. Previously Beth served in leadership roles at Bristol-Myers Squibb, Merck Research Laboratories and at Amgen, where she was chief medical officer and head of global development. In these roles she developed new treatments for AIDS, arthritis, asthma, cancer and psoriasis, cardiovascular, metabolic, neurological and renal disorders for more than 20 years. and introduced 10 innovative products to market. Beth received her M.D. from the University of Miami School of Medicine. She completed her medical residency at Johns Hopkins University and George Washington University, and her fellowship at the National Institutes of Health. She

Source (opens in a new tab)